NEWSWIRETODAY Press Release& Newswire Distribution | HOME
MOST TRUSTED NEWSWIRE PRESS RELEASE DISTRIBUTION
PRTODAY / NewswireToday press release distribution service network
Written by / Agency / Source: Frost & Sullivan
Check Ads Availability|e-mail Article

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

New, Cost-Effective Surgical Tools to Drive Ophthalmological Surgery Says Frost & Sullivan - New analysis from Frost & Sullivan, Innovative Surgical Devices for Human Vision Disorders, finds that the ophthalmology medical devices market is growing dynamically at present and is anticipated to continue with this growth trend
New, Cost-Effective Surgical Tools to Drive Ophthalmological Surgery Says Frost & Sullivan

 

NewswireToday - /newswire/ - Mountain View, CA, United States, 2009/09/01 - New analysis from Frost & Sullivan, Innovative Surgical Devices for Human Vision Disorders, finds that the ophthalmology medical devices market is growing dynamically at present and is anticipated to continue with this growth trend.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Medical Services / Equipment Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

The ophthalmology medical devices industry currently represents a dynamic industrial sector in which devices that enable minimally invasive surgery will show substantial growth, especially as these procedures have become the norm for more individualized treatments.

Implantable ophthalmologic medical devices offer scientific challenges that are undoubtedly difficult, although not impossible, with the path to success already discernible. Moreover, severe eye disorders are debilitating, but not terminal.

New analysis from Frost & Sullivan (technicalinsights.frost.com), Innovative Surgical Devices for Human Vision Disorders, finds that the ophthalmology medical devices market is growing dynamically at present and is anticipated to continue with this growth trend over the next three to four years.

If you are interested in a virtual brochure, which provides a brief synopsis of the research and a table of contents, then send an email to Jake Wengroff, Corporate Communications, at jake.wengroff[.]frost.com, with your full name, company name, title, telephone number, company email address, company website, city, state and country.

"An emerging trend in the ophthalmological surgical devices industry is the increased attention towards various sub-types of eye disease clusters - the main driver for innovations," notes Technical Insights Senior Research Analyst Prasanna Vadhana Kannan. "The awareness generated about the unique advantages of such surgeries amongst patients is paving the way for immense growth in the implantable devices market."

A wide gamut of ophthalmic diseases, including age-related macular degeneration (AMD), cataracts, glaucoma, and dry eye syndromes have resulted in potentially compromised vision and debilitating vision loss. An aging population, changing lifestyles, and a highly demanding working environment leading to stress in the eyes are impelling healthcare officials to opt for ophthalmic-related diagnosis and surgical treatment to improve, restore, and preserve sight. Within the next few years, the implantable devices sector is anticipated to grow dramatically, superseding the market share of contact lenses, glasses, and ophthalmologic drugs.

The dearth of patient compliance data and the requirement for effective training programs for surgeons and physicians have increased. There has been a surge in innovation in terms of both devices as well as the procedural levels in the ophthalmological surgical devices market.

Surgeries have gradually shifted from being invasive to non-invasive, causing less trauma to the patient. The launch of such novel technologies has necessitated that ophthalmologic surgeons undergo frequent training even while existing systems are continuously upgraded. For hospital authorities, the introduction of novel products demands greater investment, posing a key challenge in conditions where there are healthcare budgetary constraints.

The current ophthalmological surgical devices industry trend is towards newer products based on innovative technologies such as accommodative lenses, implantable retinal prosthetics, and laser in situ keratomileusis (LASIK). These have largely replaced the widespread utilization of conventional treatment approaches.

"Intensive research is underway to effectually analyze the biocompatibility of these novel treatments along with the strengthening power needed to repair visual disorders with minimal side effects, all at lower costs," remarks Kannan. "However, investigations done by researchers have failed to examine patient compliance to the novel treatment approaches that have been developed."

The ophthalmic surgical devices market being highly segmented, product suite expansion is the key factor for all major multinational firms to exhibit growth.

"By harnessing nanotechnology breakthroughs, tissue engineering, and regenerative medicine constructs, along with a combination of unique molecular diagnostic tools, researchers are now equipped with a wide range of opportunities for taking ophthalmic surgical treatments to the next level," concludes Kannan. "This next level will transform ophthalmic surgical interventions from generalized therapies to highly personalized medicine."

Innovative Surgical Devices for Human Vision Disorders, a part of the Technical Insights subscription, provides a technology overview and outlook for the surgical devices for human vision disorders technology. The study provides identification of key areas where research efforts should be directed and guide in developing blindness prevention strategies. Further, this research service includes detailed technology analysis and industry trends evaluated following extensive interviews with market participants.

Technical Insights is an international technology analysis business that produces a variety of technical news alerts, newsletters, and research services.

About Frost & Sullivan

Frost & Sullivan, the Growth Partnership Company, enables clients to accelerate growth and achieve best in class positions in growth, innovation and leadership. The company's Growth Partnership Service provides the CEO and the CEO's Growth Team with disciplined research and best practice models to drive the generation, evaluation, and implementation of powerful growth strategies. Frost & Sullivan leverages over 45 years of experience in partnering with Global 1000 companies, emerging businesses and the investment community from more than 35 offices on six continents.

Innovative Surgical Devices for Human Vision Disorders / D19E

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Medical Services / Equipment Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: Frost & Sullivan

 
 

Availability: All Metropolitan Area

 

Traffic Booster: [/] Quick NewswireToday Visibility Checker

 

Distribution / Indexing: [+]  / [Company listed above is a registered member of our network. Content made possible by PRZOOM / PRTODAY indexing services]

 
 
# # #
 
 
  Your Banner Ad showing on ALL
Medical Services / Equipment articles,
CATCH Visitors via Your Competitors Announcements!


New, Cost-Effective Surgical Tools to Drive Ophthalmological Surgery Says Frost & Sullivan

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name NewswireToday and LINK as the source.
 
Publisher Contact: Jake Wengroff 
210.247.3806 jake.wengroff[.]frost.com
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Frost & Sullivan securities in any jurisdiction including any other companies listed or named in this release.

Medical Services / Equipment via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From Frost & Sullivan / Company Profile


Read Medical Services / Equipment Most Recent Related Newswires:

Bruker Launches IconIR Nanoscale IR Spectroscopy Platform
Artificial Intelligence to Boost the Global Wound Care Market by 2026 with Minimal Intervention Solutions Finds Frost & Sullivan
Imec Signs Licensing Agreement with miDiagnostics to Commercialize its Patented Technology for Fast and Reliable COVID-19 Diagnosis
Withings Announces the FDA Clearance of ScanWatch its Most Medically Advanced Hybrid Smartwatch
Bruker Launches the Q4 POLO - Compact Spark-OES Metals Analyzer
Respiratory Health Management Market to Expedite Digital, Smart, and Portable Solutions Says Frost & Sullivan
Bruker Joins PANACEA Network to Broaden Access to NMR for European Chemistry Community
High-end Global Computed Tomography Purchases to Propel the High-end CT Segment Revenue Finds Frost & Sullivan
KRAIBURG TPE Introduces Ergonomically Designed Healthcare Equipment
Fujifilm Lauded by Frost & Sullivan for Disrupting the Operating Room Space with its Systems Integration Solution
BASF’s Irgastab® Enables LOTTE Chemical to Deliver High-clarity Medical Polypropylene for Syringes Used in COVID-19 Vaccinations
Withings and One Drop Partner to Bring Best-in-class Medical Devices to Multi-condition Employer Program
BIOTRONIK Applauded by Frost & Sullivan for its Disruptive Implantable Cardiac Monitoring Device, BIOMONITOR IIIm
Sensor Technologies for Pressure Injury Prevention Improve Outcomes and Operational Efficiency for Hospitals Finds Frost & Sullivan
New Bruker NMR Life Science Research Solutions Enable Functional Structural and Cellular Biology Research

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  Limelon Advertising, Co.

Visit  MONOVERSE USA, Inc.





 
  ©2021 NewswireToday — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com newswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are proudly NOT affiliated with USA TODAY (usatoday.com)